Sandy Hatten

Track

Insider profile

Currently holds a position at Avadel Pharmaceuticals PLC

Performance

Overall performance
2.2
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 5% 8.2% 15.1%
Success rate 89% 68% 82%
Transactions
4 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -65%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Senior Vice President - Quality and Regulatory Affairs Avadel Pharmaceuticals PLC June 26, 2015 -
Senior Vice President - Quality and Regulatory Compliance Keenova Therapeutics PLC None -
Sandy Hatten's trades of Avadel Pharmaceuticals PLC's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2019-12-16 2019-12-12
S Sale
72,197 -23.3%
34.88
US$4,610,299 		72,197 -23.3% 34.88 US$4,610,299
2018-12-18 2018-12-14
S Sale
21,100 +34.3%
289.62
US$3,903,126 		21,100 +34.3% 289.62 US$3,903,126
2017-09-15 2017-09-12
B Purchase
13,094 +19.2%
63.63
US$215,858 		13,094 +19.2% 63.63 US$215,858
2016-03-21 2016-03-18
B Purchase
3,000 +inf%
11.01
US$33,030 		3,000 +inf% 11.01 US$33,030